Abstract
A new study by Islam et al, in this issue of EMBO Molecular Medicine, reports three microRNAs in the blood that are linked to inter-individual differences in cognition, prior to any sign of cognitive decline. The novel miRNA biomarkers may assist in predicting the risk of cognitive decline and later of developing dementia and can contribute to decision strategies about early therapeutic interventions.
Original language | English |
---|---|
Article number | e14997 |
Journal | EMBO Molecular Medicine |
Volume | 13 |
Issue number | 11 |
DOIs |
|
State | Published - 8 Nov 2021 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine